Docstoc

Chinese Antibiotics Market 2008-2009 Forecast and Investment Report

Document Sample
Chinese Antibiotics Market 2008-2009 Forecast and Investment Report Powered By Docstoc
					Chinese Antibiotics Market 2008-2009 Forecast and Investment Report
Source: China Industry Research Report Network
?
Report Name】 【Chinese Antibiotics Market 2008-2009 Forecast and Investment
Report
【Keywords】 Antibiotics Market Analysis Industry Analysis Forecast of Investment
Prospect
【Published】 2008
【】 Email electronic delivery / EMS 00
【 Price 】 paper dielectric Edition: 6800 yuan electronic version: 7,000 paper
dielectric + e: 7200 yuan
【Telephone Order】 010-80993936 80993963
?
Chapter 2008 Environmental Analysis of Antibiotics industry
1 ,2007-2008 analysis of China's economic development environment
(A) macro-economic operation in China in 2007
(B) the trend of economic growth in 2008 forecast
(3) May 2008 PPI rose 8.2%
2, 2008, China's industry policy environment of antibiotic
(A) trade policy analysis
(B) of the policy implications of pharmaceutical industry
(C) Import and Export Trade Policy Analysis

Chapter 2008, Globalization of antibiotic Market Watch
1, 2008, impact of globalization on China's Pharmaceutical Market
(A) medical industrial restructuring in the global division of labor
(B) of the pharmaceutical market in the globalization process accelerated
(C) of the global status of China's pharmaceutical industry
(D) of the 2009-2012 status of China in the global pharmaceutical market forecast
2, 2008, analysis of economic globalization, economic security,
(A) of the developing countries to participate in economic globalization
(B) of the developed countries to implement the strategic intent of economic
globalization
(C) the impact of globalization economic security of developing countries
3, 2008, Globalization and Risk Analysis of bulk drugs industry
4, 2008, Globalization and the pharmaceutical quality control
5, 2008, Globalization and the API trade analysis
6, 2008, R & D progress of globalization and the antibiotic
(A) the global research and development of new antibiotics
(B) New Development of the United Kingdom Antibiotics

Chapter 2008 of Antibiotics industry situation analysis
1, 2008, Development of China's antibiotic market
(A) of the antibiotics market analysis
(B) of the 2008 industrial boom of antibiotics
(C) 2008 China Antibiotics Market Situation
(D) serious waste of antibiotic drugs
(E) 2008 antibiotic intermediate 7-ADCA API market outlook
Second, the 2008 development trend of China Antibiotics Market
(A) of the 2008 upstream development of antibiotic
(B) of the birth of new antibiotic resistant
(C) 2008, the development of antibiotics should be                            "API
innovation"
3, 2008, our analysis of price movements of antibiotics
(A) of the 2008 price of antibiotics
(B) of the 2008 industry into high-cost antibiotic era

Chapter IV antibiotics industry trade of China in 2008 to run Dynamic Analysis
1, 2008, China's total import and export trends of antibiotic
(A) the amount of China's import trends in antibiotic
(B) trends in China's export value of antibiotics
(C) trends in imports of Chinese antibiotic products
(D) the number of Chinese exports trend of antibiotics
2, 2008, China's global trade structure of antibiotics
(1) China's global trade, the overall trend of antibiotics
(2) China's global trade trends in various regions of antibiotics
(C) Domestic exports of the regional structure of Antibiotics
(D) Structure of China's trade patterns of antibiotics

Chapter 2008 of the Chinese market segments antibiotics - quinolones
I. Overview of quinolones in China in 2008
(A) Overview of quinolones
(B) of the endless variety of quinolone
(C) quinolones API production of all varieties
(D) demand for products of quinolones
Second, the 2008 market share of quinolones
(A) of Shenyang
(B) market share analysis in Shanghai
(C) market share analysis in Qingdao
(D) market share analysis in Jinan
(E) market share analysis in Foshan
(Vi) market share analysis in Beijing
3, 2008, China fluoroquinolone antibiotics Hospitals Observation Well ketone
4 ,2009-2012 development trend of China quinolones

Chapter 2008 of the Chinese market segments antibiotic - macrolide
First, the five cities the retail market structure of macrolide antibiotics
(A) of the different category structures
(B) structural analysis of different dosage forms
2, 2008, the market structure in different parts of macrolide antibiotics
(A) the market structure of macrolide antibiotics in Qingdao
(B) the market structure of macrolide antibiotics in Jinan
(C) of macrolide antibiotics in Shenyang market structure
(D) the market structure of macrolide antibiotics in Shanghai
(E) the market structure of macrolide antibiotics in Foshan
(F) the market structure of macrolide antibiotics in Beijing
3 ,2009-2012 development trend of China's analysis of macrolide
antibiotics

Chapter VII of the 2008 analysis of China's antibiotic market segments -
cephalosporins
1, 2008, cephalosporin use to observe and analyze the hospital
(A) of the cephalosporin dosage forms of development and change
(B) changes in market concentration
(Iii) competitive market for alternative products
(D) observation of key species
2, 2008, and Antibiotics Market Watch
Third, observation of cephalosporin antibiotics market hotspots
4, 2008, China's regulation of cephalosporins
5, 2008, China's regional structure of cephalosporins
(A) of the cephalosporin market in Beijing
(B) in Shenyang cephalosporin market
(C) Qingdao cephalosporin drug structure
(D) of the Jinan region structure of cephalosporins drug
(E) Foshan region cephalosporin drug structure
(F) in Shanghai cephalosporin drug structure
(G) The Second Hospital of Zhejiang University School of Medicine Application of
cephalosporins

Chapter VIII of the 2008 analysis of China's antibiotic market segments -
Penicillin
1, 2008 changes in China's production of penicillin
2, 2008, the price trends of China's penicillin
3, 2008, the Chinese market trade of penicillin
(A) of the total exports in 2008 penicillin
(B) export prices in 2008 penicillin
4, 2008, the global market trend of penicillin
(A) of the penicillin market in India
(B) of the United States penicillin market
5, 2008, a typical Chinese market analysis of penicillin drugs
(A) of the major cities in the retail market structure of penicillin drugs
(B) sub-area drug market structure of penicillin
Chapter 2008 of China's antibiotic market segments - peptide
I. Glycopeptides
Second, vancomycin class
(A) vancomycin
(B) Norvancomycin
(C) teicoplanin
3, 2008, the use of vancomycin abroad
(1) Orly million stars (Oritavancin, LY-333328)
(B) Dabbeh million stars (Dalbavancin, V-glycopeptide BI397)
(3) Terra Wan Star (Telavancin, TD-6424)
IV lipopeptide
(A) of daptomycin (daptomycin)
(B) Ramoplanin (ramoplanin)
5, 2008, China's other peptide antibiotics
(A) of polymyxin (Polymyxin)
(B) Bacitracin (Bacitracin)
(C) capreomycin (Capreomycin)
(4) of bleomycin (Bleomycin, BLM) and Pingyangmycin (Pingyangmyein)
(E) actinomycin D (Actinomycin D, ACTD)
6, 2008 SWOT Analysis of the Chinese market peptide antibiotics

Chapter 2008, the Chinese industry competition pattern of antibiotic
1, 2008, the global competition of antibiotics
(A) of the product life cycle analysis
(B) Competition Trend Analysis
(C) analysis of price competition
Second, the 2008 competition in China Analysis of antibiotics
(A) of the antibiotic manufacturers develop technology to enhance competitiveness
(B) of the antibiotics market competition in 2008 upgrade
(C) of the antibiotics market brand competition analysis
3 ,2009-2012, competition in China's antibiotic market trend forecast of the
industry

Chapter XI of Antibiotics industry, business analysis edge
1, Harbin Pharmaceutical Group Pharmaceutical Factory
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
2, Jun-Pharmaceutical Co., Ltd. Shenzhen To
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
3, General Pharmaceutical Factory, Guangzhou Baiyun Mountain
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
4, Hainan General Sanyo Pharmaceutical
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
5, Pfizer
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
6, Shanghai Roche Pharmaceuticals
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
7, Shijiazhuang Pharmaceutical Group
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
8, the federal drug
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
9, Henan Xinxiang Huaxing Pharmaceutical
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy
10, North China Pharmaceutical
(A) Company Profile
(B) analysis of enterprise performance
(C) Business Development Strategy

Chapter XII of the Chinese pharmaceutical industry in 2008 Situation Analysis
Market
1, 2008, the development of China's pharmaceutical industry
(A) the opportunities facing our national pharmaceutical analysis
(B) economic operation of the pharmaceutical industry
Second, market analysis in 2008 API
(A) the prospects of China's Pharmaceutical Market
(B) situation analysis of bulk drug industry
(C) Import and Export Analysis of China Pharmaceutical Raw Materials
3, 2008, China's drug safety monitoring situation
(A) Overview of Drug Supply, Quality and Safety
(B) of the Drug Safety Supervision System and Legal System
(C) of the drug safety monitoring of policies and measures
(D) the regulation of Chinese medicine and folk medicine
(E) the global exchange of drug safety monitoring and cooperation

Chapter XIII 2009-2012 China industry development and investment analysis of
antibiotics
1 ,2009-2012, Trend Analysis of China's R & D of antibiotics
(A) research and development of new trends in antibiotic
(B) of the new β- lactam antibiotics
II ,2009-2012 Market Forecast and Analysis of antibiotics in China
(A) prediction of fluoroquinolone antibiotics
(B) Prediction of the use of antibiotics
(C) Forecast of Price Trend of China's antibiotic
3 ,2009-2012, industry investment analysis of antibiotics in China
(A) of the Investment Environment of China antibiotics Industry
(B) investment opportunities in China Antibiotic Industry Analysis
(C) China Investment Risk Analysis of Antibiotic Industry


Chart catalog (part):
Chart: 1995 -2,007 of the National grain output
Chart: 1995 -2,007 analysis in national industrial value added
Chart: -2,007 1995, the National Investment in Fixed Assets
Chart: -2,007 1995 Total Retail Sales of Consumer Goods
Chart: from January to December 2007 CPI index map
Chart: from January to December 2007 CPI index table
Chart: 1995 -2,007 total import and export
Chart: 1995 in per capita rural income -2,007
Chart: -2,007 in 1995 per capita disposable income of urban residents
Chart: January 2007 -2008 in May CPI and PPI Chart
Chart: A Brief ... ...
See report text for more charts

				
DOCUMENT INFO